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 We studied five patients diagnosed with primary gastric 
lymphoma between 1985 and 1995 in Omura Munisipa Hos-
pital to investigate the relationship between Helicobacter 
pylori, Epstein-Barr virus and primary malignant gastric 
lymphoma. H. pylori was detected by hematoxylin-eosin stain, 
Giemsa stain, immunohistochemistry while EBV was de-
tected by in situ hybridization in the lymphoma and back-
ground mucosa. H. pylori but not EBV, was detected in all 
cases. Furthermore, malignant lymphomas were mainly lo-
cated in the area of the fundic gland where H. pylori was 
frequently identified and caused inflammation. In contrast, 
malignant lymphomas were not detected in areas with in-
testinal metaplasia. Our results suggest that malignant lym-
phoma may develop in a region where the immune system 
has been activated by H. pylori. In contrast, EBV is unlikely 
to play an important role in the development of gastric 
lymphoma, compared to H. pylori.
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Introduction 
 The discovery of Helicobacter pylori has changed the 
conventional concept of gastroduodenal disease (1-6). 
Furthermore, current advances in molecular biology
have enhanced the elucidation of the role played by H. 
pylori infections (1-6) and certain viral diseases in the 
development of gastrointestinal malignancies (7-20). In 
this study, we investigated the relationship between H. 
pylori, EBV and primary gastric malignant lymphoma 
(PGML), as well as the relationship between these dis-
eases and background gastric mucosa in five cases of 
PGML.
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Materials and Methods 
Patients 
 Between 1985 and 1995, five patients were diag-
nosed with PGML in Omuta Municipal Hospital. They 
included three females and two males with an average 
age of 51.6 years (range, 35 to 74 years). Treatment 
included total gastrectomy in three and distal 
gastrectomy in the other two. Macroscopically, the 
tumor was of the ulcerative type in four and protrud-
ing type in one (Table 1). 
Tissue preparation and staining 
 Surgical specimens were fixed in formalin, embedded 
in paraffin wax, and stained with hematoxylin-eosin 
(H&E), Giemsa, and periodic acid Schiff. Histopathologic 
diagnosis of all PGML was based on the Japanese LSG 
classification criteria. The distribution of H. pylori was 
examined in H&E stained sections, and Giemsa stained 
sections of the lesser curvature of the resected stom-
ach. We also examined the relationship between PGML 
and background mucosa including inflammation, atro-
phy, and intestinal metaplasia.
Table 1. The clinical and histological results 
                      Case 1 Case 2 Case3 Case 4 Case5 
Age 74 42 48 35 59 
Gender F F M F M 
Symptoms Hematoemesis Eigastralgia Epigastralgia Nausea Epigastralgia 
Location CM CM M AM MCA 
 Size 6.5x6.0 7.0 x 6.0 4.5 x 3.5 7.0 x 6.0 11 x 8.5 
Macroscopic finding Ulcerative type Ulcerative type Ulcerative type Ulcerative type Protruding type 
Microscopic finding Diffuse Diffuse Diffuse Diffuse Diffuse 
(LSG classification) large cell type large cell type large cell type large cell type large cell type 
MALT component (-) (-) (-) (-) (-) 
 Invasion depth ssr mp mp sm mp 
Stage IV I I III IV 
 H.pylori positive positive positive positive positive
Immunohistochemistry 
 Immunohistological studies were performed by the 
avidin-biotin-peroxidase complex method using paraffin-
embedded sections prepared from specimens fixed in 
10% formaldehyde. The following mouse monoclonal 
primary antibodies or rabbit polyclonal primary anti-
bodies were used at appropriate dilutions: UCHL1; L26, 
anti-H. pylori IgG used in this study were purchased 
from Dako Japan (Tokyo). 
In-situ hybridization (ISH) of EBV 
 To determine the localization of EBV, ISH studies 
were carried out using EBV-encoded small RNA 1 and 
2 (EBER) sequences as a target. A commercially avail-
able fluorescein-conjugated oligomer sequence served 
as a complementary probe (DAKO). Tissue sections (6 
,um thick) were deparaffinized, dehydrated, treated with 
proteinase K, dehydrated and air-dried. Hybridization 
was performed for 2 h at 371C in a humid chamber. 
After washing, detection of EBV was achieved using a 
mouse anti-FITC antibody, an alkaline phosphatase-
conjugated rabbit anti-mouse antibody, BCIP/NBT devel-
opment and Fast Red counterstaining. EBV-positive 
tonsil specimens from a patient with infectious mono-
nucleosis and samples of EBV-related nasopharyngeal 
carcinoma were used as positive controls.
Results 
Histopathologic findings 
 Morphological changes: All cases were classified as 
diffuse lymphoma, large cell type based on LSG
classification (Fig.lc). The depth of invasion was 
submucosa in one, muscularis propria in three, 
subserosa g in one. Clinical staging was stage 1 in two 
patients, stage 3 in one and stage 4 in two patients. In 
all cases, no component of mucosal associated lymphoid 
tissue (MALT) lymphoma was observed (Table 1). 
 Relationship between PGML and lymphoid follicles, 
neutrophils, atrophy, metaplasia, and H. pylori: In three 
cases, the PGML lesion was located in the fundic 
gland region (Cases 1, 2, 3), while in the other two 
cases (Cases 4, 5), the lesion involved the fundic and 
pyloric glands, but the main lesion was located in the 
fundic gland (Fig. 2a-e). None of the lesions was lo-
cated in areas of intestinal metaplasia. Lymphoid folli-
cles were observed in all tissue samples. H. pylori 
mainly distributed in the fundic glands but was not 
found in the area of the pyloric gland showing intesti-
nal metaplasia. In Cases 1, 2, H. pylori was detected fo-
cally or in patches, respectively, over the area of the 
fundic glands. In Cases 3, 4, 5, abundant H. pylori was 
present diffusely in the area of the fundic glands and 
pyloric glands (Fig. la, b). Neutrophil infiltration was 
observed in the areas showing diffuse distribution of 
H. pylori .
Immunohistochemical studies of PGML and H. pylori 
 H. pylori: Spiral organisms positive for the antibody 
to H. pylori were detected in all cases (Fig. 3a). 
 PGML: Neoplastic cells were positive for L26 (Fig. 
3b), but negative for UCHL1 in all cases (Fig. 3c). 
In-situ hybridization (ISH) of EBV 
 Neoplastic and normal lymphocytes as well as the
a) The affected fundic mucosa with H. pylori shows features 
of moderate chronic active gastritis with neutrophil infiltra-
tion in the pits and lamina propria (H&E, X400).
b) Abundant H. pylori diffusely distributed near the lesion 
involving the fundic gland (Giemsa stain 600).
Fig 1. Microscopic findings in the stomach of a representative patient (Case 3).
gastric mucosa around the lesion were negative for 
BHLF and EBER in all cases (Fig. 4a). The control 
case of malignant lymphoma with an infection of EBV 
was positive for BHLF and EBER (Fig. 4b).
Discussion 
 Primary extranodal non-Hodgkin's lymphomas occur-
ring in the gastrointestinal tract frequently differ from 
lymphomas arising in lymph nodes or in other pri-
mary lymphoid organs such as the spleen, tonsils, skin, 
and thymus. Gastrointestinal lymphomas usually dis-
play a B-cell phenotype, and are believed to originate 
from cells of the mucosa-associated lymphoid tissue 
(2).
 Warren and Marshall discovered the spiral urease-
producing H. pylori in the human stomach in 1983 (1), 
and this organism is now known to be associated with 
gastroduodenal disease including gastric and duodenal 
ulceration (2-6). Recently, H. pylori was also consid-
ered to be strongly associated with gastric lymphoma 
(3-6). For example, Wotherspoon et al. (4) examined 
110 cases of gastric MALT and found H. pylori infec-
tion in 101 of these cases (92%). In addition, other 
groups reported that eradication of H. pylori by antibi-
otic therapy produced a regression of gastric lym-
phoma arising from mucosa-associated lymphoid tissue 
(5, 6). However, to date there is no direct evidence 
that H. pylori causes gastric malignant lymphoma. 
 Current advances in molecular biology using 
polymerase chain reaction and in situ hybridization
Fig 2. Relationship between PGML and lymphoid follicles, neutrophils, atrophy, metaplasia, and H. pylori.
a) Immunohistology demonstrating the presence of spiral or-
ganisms positive for IgG-H. pylori (ABC 600).
b) Neoplastic cells were positive for L26.
c) Neoplastic cells were negative for UCHLI.
Fig 3. Immunohistochemical findings in a representative patient (Case 3).
a) Neoplastic cells in a case of generalized malignant lym-
phoma.
b) Neoplastic and normal lymphocytes as well as gastric 
mucosa around the lesion were negative for BHLF and EBER 
in all cases.
Fig 4. In situ hybridization of generalized and gastric lymphoma.
have made it possible to determine the involvement of 
oncogenic viruses, such as EBV, hepatic B virus, 
HTLV-1, and certain human papilloma viruses, in the 
development of a large proportion of certain types of 
human cancers (7-20). Recently, EBV was confirmed 
to be associated with a variety of neoplasms including 
Hodgkin's disease, B cell lymphoma in immunodeficient 
individuals, T cell lymphoma, nasopharyngeal lymphe-
pithelioma, and gastric carcinoma with massive 
lymphocytic infiltration (8-20). 
 EBV infects B cells and exhibits strong tropism for 
human B cells. The infected B cells are immortalized 
and can be propagated in vitro (17). However, EBV is 
a ubiquitous and asymptomatic virus because EBV in-
fection is readily controlled by effective immune re-
sponses in normal individuals (17). In Africa, 
immunological disorders due to malaria infection pro-
mote the development of Burkitt's lymphoma along 
with EBV infection and gene-related factors (19, 20). 
We consider PGML similar to Burkitt's lymphoma 
with regard to the following characteristics: 1) It fre-
quently originates from B lymphocytes, and 2) it 
causes chronic active gastritis associated with H. pylori 
that may impair or activate local immune competence 
in the stomach. We therefore postulated that H. pylori 
and oncogenic viruses, such as EBV, may mutually be 
involved in the development of PGML. The present 
study investigated the prevalence of H. pylori and EBV 
in five patients with PGML, and also examined the re-
lationship between these diseases and the background 
gastric mucosa. 
 The major findings of our study were: 1) malignant 
lymphoma was mainly located in the area of the 
fundic glands where H. pylori is frequently distributed 
and caused inflammation, and was not found in areas 
showing intestinal metaplasia. 2) In all cases of malig-
nant lymphoma, H. pylori but not EBV, was detected 
in gastric tissues. The above first major finding sug-
gests that PGML may arise in regions where H. pylori 
has activated the immune system. The second major 
finding suggests that EBV does not play an important 
role in the development of PGML, compared with H. 
pylori. With regard to the relationship between pri-
mary gastric lymphoma and EBV, Qiang et al. (16) ex-
amined 49 cases of primary gastric lymphomas con-
sisting of low-grade MALT (16 cases), centroblastic (30 
cases) and immunoblastic (3 cases) subtypes. They de-
tected EBV in two cases of MALT and two cases of 
the centroblastic subtype (8%). On the other hand, Ott 
et al. (17) examined 55 cases of primary gastric lym-
phoma consisting of low-grade MALT (27 cases), 
centroblastic (22 cases), immunoblastic (2 cases), large 
cell anaplastic (3 cases), and T-pleomorphic (1 case)
subtypes. They demonstrated that primary gastric B-
cell lymphoma of MALT and large cell anaplastic type 
were clearly negative for EBV mRNA, while three 
PGML were positive for EBV. In two of the three 
cases, primary gastric B-cell lymphoma clearly arose 
from a low grade lymphoma of MALT type that was 
positive for EBV. The above studies suggested that 
EBV is not particularly associated with primary gas-
tric lymphoma (13-15). However, these studies indi-
cated that the prevalence of EBV in PGML ranged 
from 5 to 8% (16, 17). Furthermore, recent studies 
showed that EBV was detected in 6 to 15% of patients 
with gastric carcinoma (9-15). This suggests that EBV 
may play a role in the development of PGML and car-
cinoma of the stomach. However, due to the small 
sample size in the present study, no firm conclusions 
could be made regarding the prevalence of EBV in 
gastric carcinoma. Further studies are required to in-
vestigate how oncogenic viruses including EBV are as-
sociated with the development of gastric neoplasms.
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